Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer
Open Access
- 1 January 2003
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 9 (2) , 377-380
- https://doi.org/10.3748/wjg.v9.i2.377
Abstract
AIM: To investigate the effects of inhibiting factor of cell cycle regulation p57kip2, retinoblastinoma protein (Rb protein) and proliferating cell nuclear antigen (PCNA) in the genesis and progression of human pancreatic cancer. METHODS: The expression of p57kip2, Rb protein and PCNA in tumor tissues and adjacent tissues of 32 patients with pancreatic cancer was detected with SP immunohistochemical technique. RESULTS: p57kip2 protein positive-expression rate in tumor tissues of pancreatic cancer was 46.9%, which was lower than that in adjacent pancreatic tissues (75.0%) (χ2 = 5.317, P < 0.05), p57kip2 protein positive-expression correlated significantly with tumor cell differentiation (well-differentiation versus moderate or low-differentiation, P < 0.05) but did not correlate significantly with lymph node metastasis (lymph node metastasis versus non-lymph node metastasis, P > 0.05); Rb gene protein positive-expression rate in tumor tissues was 50.0%, which was also lower than that in adjacent pancreatic tissues (78.1%) (χ2 = 5.497, P < 0.05); PCNA positive-expression rate was 71.9%, being higher than that in adjacent pancreatic tissues (43.8%) (χ2 = 5.189, P < 0.05), PCNA positive-expression also correlated significantly with tumor cell differentiation and lymph node metastasis (well-differentiation versus moderate or low- differentiation, lymph node metastasis versus non-lymph node metastasis, P < 0.05). Rb protein positive-expression rate in the tumor tissues of p57kip2 protein positive-expression group was 53.3%; and Rb protein positive-expression rate in the tumor tissues of p57kip2 protein negative-expression group was 47.1%. There was no significant relationship between the two groups (r = 0.16507, P > 0.05). CONCLUSION: The decreased expression of p57kip2, Rb protein or over-expression of PCNA protein might contribute to the genesis or progression of pancreatic cancer, p57kip2, Rb protein and PCNA may play an important role in genesis and progression of pancreatic cancer.Keywords
This publication has 30 references indexed in Scilit:
- Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cellsOncogene, 2001
- Contributions in the domain of cancer research: Review¶Negative regulators of cyclin-dependent kinases and their roles in cancersCellular and Molecular Life Sciences, 2001
- Cancer Cell CyclesScience, 1996
- Cell Cycle and CancerJNCI Journal of the National Cancer Institute, 1995
- Cell-cycle regulators and cancerTrends in Genetics, 1995
- p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.Genes & Development, 1995
- Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.Genes & Development, 1995
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- G1 phase progression: Cycling on cueCell, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994